2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHLindolent B-cell non-Hodgkin lymphomaRecruitingPhase 1 / Phase 22026-10-02NCT03571568
A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, metastatic malignant neoplasm, neoplasmRecruitingPhase 32025-10-15NCT06174987